Xtant Medical

Xtant Medical Reports Second Quarter 2017 Financial Results

Company Continues to Take Steps During Restructuring to Build for Future Growth
BELGRADE, Mont., Aug. 09, 2017 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today reported its financial results for the quarter ended June 30th, 2017. The Company reported Second Quarter 2017 revenue of approximately $21.4 million and an EBITDA loss of approximately ($2.1) million for the period. Revenue
Consolidated second quarter 2017 revenue was approximately $21.4 million, a slight decrease compared to revenue of approximately $21.5 million for the same period of 2016.  The slight decrease was d…